Supporting the LCA community
We see a cure for blindness
What is Leber Congenital Amaurosis (LCA)?
LCA is a rare inherited retinal disease characterized by severe vision loss at birth. While some children are born with little or no vision, others may have significant vision loss in the first few years of life, stable vision for a period of time, and then eventually complete vision loss as the retina deteriorates into total blindness.
What We Do
Founded in 2014 as Sofia Sees Hope, Hope in Focus is a nonprofit 501(c)(3) patient advocacy organization dedicated to generating awareness, raising funds for research, and providing support, education and outreach to the LCA and rare inherited retinal disease community.
Thank you to these organizations
for their ongoing commitment to Hope in Focus.
Let’s Get Social!
[fts_twitter twitter_name=SofiaSeesHope tweets_count=4 cover_photo=no stats_bar=no show_retweets=no show_replies=no]
SparingVision has announced the first patient dosed in its NYRVANA Phase 1/2 clinical trial evaluating SPVN20, an innovative gene-agnostic therapy designed to restore aspects of visual acuity and color vision in people with advanced retinitis pigmentosa (RP).![]()
![]()
Delivered through a single intravitreal injection, SPVN20 reactivates dormant cone cells, light-sensing cells that survive but no longer respond to light, offering potential treatment for patients regardless of their genetic mutation.![]()
![]()
This milestone marks important progress toward expanding treatment options for those living with advanced RP, a condition that currently has no approved therapy.![]()
![]()
To read more about this, visit this link: loom.ly/-fLdim8 ![]()
Image description: White background with SparingVision logo centered in the middle.![]()
#RP #retinitispigmentosa #irds #blindcommunity #lowvision #visuallyimpaired #inclusion
Take a moment to watch this Good Morning America segment featuring Lindsey Rambo, an LCA5 patient participating in a clinical trial with Opus Genetics. Lindsey was the second person ever to receive this one-time injection in her eye and within six months, she no longer needed her mobility cane.![]()
We’re so excited to see one of our LCA community members share their story. Lindsey’s journey is an inspiring example of hope and shines a light on what’s possible for the LCA community!![]()
Watch the segment here: loom.ly/Ojr8aj4![]()
![]()
Image description: Screenshot of the segment on Good Morning America.![]()
#LCA #LCA5 #OpusGenetics #LeberCongenitalAmaurosis #HopeInFocus #BlindCommunity #LowVision #VisuallyImpaired #Inclusion